What is Piflufolastat F-18: Uses, Dosage, Side Effects and More

Piflufolastat F-18 is a specialized radioactive imaging agent used to help doctors see prostate cancer cells more clearly during PET scans. This medication works like a targeted flashlight, highlighting areas where prostate cancer may be hiding in your body so your medical team can make better treatment decisions for you.

What is Piflufolastat F-18?

Piflufolastat F-18 is a radioactive tracer that doctors inject into your bloodstream before a PET scan. Think of it as a special dye that seeks out prostate cancer cells specifically, making them glow on the imaging scan.

This medication contains a small amount of radioactive fluorine-18 attached to a molecule that binds to prostate-specific membrane antigen (PSMA). PSMA is a protein that appears in much higher amounts on prostate cancer cells compared to healthy cells.

The radioactive part of the medication is quite weak and safe for medical use. It gives off just enough signal for the PET scanner to detect, while breaking down naturally in your body within hours.

What is Piflufolastat F-18 Used For?

Doctors use Piflufolastat F-18 to find prostate cancer that may have spread beyond the prostate gland. This imaging test helps your medical team see exactly where cancer cells might be hiding in your body.

Your doctor might recommend this scan if your PSA levels are rising after prostate cancer treatment, suggesting the cancer may have returned. The scan can detect cancer in lymph nodes, bones, or other organs that might not show up clearly on regular CT or MRI scans.

This test is particularly helpful for men with recurrent prostate cancer who are considering additional treatment options. The detailed images help doctors plan the most effective approach for your specific situation.

How Does Piflufolastat F-18 Work?

Piflufolastat F-18 works by targeting a specific protein called PSMA that prostate cancer cells produce in large amounts. When injected into your bloodstream, the medication travels throughout your body and sticks to these cancer cells.

The radioactive fluorine-18 part of the medication sends out signals that the PET scanner can detect. These signals appear as bright spots on the scan images, showing your doctor exactly where prostate cancer cells are located.

This is considered a moderately strong imaging agent, meaning it provides very clear and detailed pictures. The medication typically reaches peak concentration in cancer cells within 60 to 120 minutes after injection.

How Should I Prepare for Piflufolastat F-18?

You can eat and drink normally before your scan, as food doesn't interfere with this medication. However, staying well-hydrated by drinking plenty of water helps your kidneys process the medication more efficiently.

Remove any metal objects like jewelry, belts, or clothing with metal zippers before the scan. Your medical team will provide you with a hospital gown to wear during the procedure.

Arrive at your appointment on time, as the medication is prepared specifically for your scheduled scan time. The radioactive tracer has a short half-life, meaning it loses its effectiveness quickly if not used when planned.

How Long Does the Piflufolastat F-18 Process Take?

The entire process typically takes 2 to 3 hours from start to finish. First, you'll receive the injection, then wait about 60 to 120 minutes for the medication to circulate and bind to any cancer cells.

The actual PET scan takes about 20 to 30 minutes, during which you'll lie still on a table that moves through the scanner. The waiting period allows the medication to reach the right concentration in your tissues for optimal imaging.

Most of the radioactive material leaves your body naturally through urine within 24 hours. You can resume your normal activities immediately after the scan, though you may want to drink extra water to help flush out the medication.

What Are the Side Effects of Piflufolastat F-18?

Most people experience no side effects from Piflufolastat F-18, as it's generally very well tolerated. The amount of radioactive material used is small and designed to be safe for medical imaging.

Here are the most common side effects that some people might experience, though they affect fewer than 1 in 100 patients:

• Mild nausea or stomach discomfort
• Headache
• Fatigue or feeling tired
• Dizziness
• Metallic taste in your mouth

These symptoms, if they occur, are usually mild and resolve on their own within a few hours. The radioactive exposure from this scan is similar to what you might receive from other medical imaging tests.

Rare but more serious side effects can include allergic reactions, though these are extremely uncommon. Signs of an allergic reaction might include difficulty breathing, swelling of your face or throat, or severe skin rash.

Who Should Not Take Piflufolastat F-18?

Piflufolastat F-18 is not recommended for women who are pregnant or might be pregnant, as radiation exposure could potentially harm a developing baby. If you're a woman of childbearing age, your doctor will likely require a pregnancy test before the scan.

Breastfeeding mothers should discuss timing with their doctor, as small amounts of the medication can pass into breast milk. Your doctor may recommend pumping and discarding breast milk for 12 to 24 hours after the scan.

People with severe kidney problems may need special consideration, as the medication is primarily eliminated through the kidneys. Your doctor will evaluate your kidney function before recommending this scan.

If you have a history of severe allergic reactions to other imaging agents, make sure to tell your medical team. While allergic reactions to Piflufolastat F-18 are rare, your doctor needs to know about any previous reactions.

Piflufolastat F-18 Brand Names

Piflufolastat F-18 is available under the brand name Pylarify in the United States. This is the FDA-approved version of the medication that hospitals and imaging centers use for PSMA PET scans.

Some medical facilities may refer to it simply as "PSMA PET tracer" or "F-18 PSMA" when discussing your scan. These all refer to the same medication and imaging process.

The medication is manufactured by specialized radiopharmacies and delivered fresh to imaging centers, as it must be used within hours of production due to its radioactive nature.

Piflufolastat F-18 Alternatives

Other PSMA-targeted imaging agents include Ga-68 PSMA-11, which uses a different radioactive element called gallium-68. Both medications target the same PSMA protein but use different radioactive tracers.

Traditional imaging methods like CT scans, MRI, or bone scans are still used for prostate cancer, but they may not detect small amounts of cancer as effectively as PSMA-targeted scans.

Your doctor will choose the best imaging option based on your specific situation, what's available at your medical center, and your insurance coverage. All PSMA-targeted scans provide similar valuable information about prostate cancer location.

Is Piflufolastat F-18 Better Than Ga-68 PSMA-11?

Both Piflufolastat F-18 and Ga-68 PSMA-11 are excellent imaging agents that target the same PSMA protein on prostate cancer cells. They provide similar quality images and help doctors locate prostate cancer with high accuracy.

Piflufolastat F-18 has a longer half-life, meaning it remains active for more time and may be more widely available at imaging centers. Ga-68 PSMA-11 has been used longer in research settings and may be preferred at certain medical centers.

The choice between these medications often depends on what's available at your imaging center rather than significant differences in effectiveness. Both provide your doctor with detailed information to guide your treatment decisions.